Calls for answers about PHARMAC delay after epilepsy deaths

New Zealand Herald

17 December 2019 - The Opposition is calling for answers from the Government about why it took two weeks for the public be told an epilepsy drug switch by PHARMAC had been potentially linked to three deaths.

PHARMAC on November 15 reversed a decision to move 11,000 patients from more expensive brand of the drug lamotrigine to a generic, Logem, three days after safety agency Medsafe issued a public notice.

While urging patients to continue taking Logem, Medsafe said there had been reports of suspected negative reactions to the change to the new drug by some patients, including three deaths.

Read New Zealand Herald article

Michael Wonder

Posted by:

Michael Wonder